CYC vs RHY

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

CYC

CYCLOPHARM FPO [CYC]

41LOW

RHY

RHYTHM BIO FPO [RHY]

50MEDIUM

Score Breakdown

CYC RHY
Technical
41
34
Catalyst
51
51
Sentiment
50
50
Fundamental
69
34
Momentum
39
50
Risk Gate
50
50

Key Metrics

CYC Metric RHY
$61.6MMarket Cap$32.2M
345KAvg Volume (20d)284K
N/AShort InterestN/A
$1.29052-Week High$0.280
$0.45052-Week Low$0.052
-6.7%Daily Change-3.3%
$0.490Reference Price$0.088
-49.3%ROE-190.1%
-53.3%Profit MarginN/A

Active Signals

CYC Signals

RSI drifting toward oversold territory — worth watching
Volume surging at 2.7x normal while price falls — heavy selling pressure
Watch out — volume is flowing out even as price holds up. Distribution pattern
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.5 quarters)
Low P/S ratio (1.9x)
Moderate revenue growth (+10%)
EPS estimates revised upward (+10pts)

RHY Signals

RSI drifting toward oversold territory — worth watching
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Broke below 20-day support — that's a level the market was defending, and it just gave way
Lagging the Small Ords index — relative strength of 0.82, underperforming its peers
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.1 quarters)
Revenue in sharp decline (-49%)

Ask Scout AI to compare CYC and RHY in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

CYC vs TRI →DXB vs ENL →DXB vs EZZ →DXB vs HIQ →DXB vs ILA →
CYC Full Analysis → RHY Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).